Filed: 5/15/2024ACC: 0001892688-24-000066
📋 What this filing means
DARWIN GLOBAL MANAGEMENT, LTD. filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $751.17M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$751.17M
Total AUM (reported)
16.49M
Total Shares
Allocation by class
COM$733.22M97.6%
COM NEW$17.95M2.4%
Portfolio Concentration
Top 3$390.87M52.0%
4–10$339.15M45.1%
11–25$21.15M2.8%
Top 3 weight
52.0%
Top 10 weight
97.2%
Voting Authority Distribution
Total shares with voting rights: 16.49M
Sole
Full voting authority
16.49M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
VAXCYTE INC
SOLEShares2.75M
TypeSH
Market value$187.91M
25.02%
Sole
2.75M
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares1.44M
TypeSH
Market value$107.90M
14.36%
Sole
1.44M
Shared
0.00
None
0.00
KEROS THERAPEUTICS INC
SOLEShares1.44M
TypeSH
Market value$95.06M
12.65%
Sole
1.44M
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares1.48M
TypeSH
Market value$80.78M
10.75%
Sole
1.48M
Shared
0.00
None
0.00
ALPINE IMMUNE SCIENCES INC
SOLEShares1.98M
TypeSH
Market value$78.57M
10.46%
Sole
1.98M
Shared
0.00
None
0.00
BEAM THERAPEUTICS INC
SOLEShares2.12M
TypeSH
Market value$70.03M
9.32%
Sole
2.12M
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares832.20K
TypeSH
Market value$55.30M
7.36%
Sole
832.20K
Shared
0.00
None
0.00
XENCOR INC
SOLEShares1.11M
TypeSH
Market value$24.56M
3.27%
Sole
1.11M
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares473.20K
TypeSH
Market value$17.95M
2.39%
Sole
473.20K
Shared
0.00
None
0.00
ELEVATION ONCOLOGY INC
SOLEShares2.33M
TypeSH
Market value$11.97M
1.59%
Sole
2.33M
Shared
0.00
None
0.00
TOURMALINE BIO INC
SOLEShares465K
TypeSH
Market value$10.65M
1.42%
Sole
465K
Shared
0.00
None
0.00
MERCK & CO INC
SOLEShares79.60K
TypeSH
Market value$10.50M
1.40%
Sole
79.60K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
VAXCYTE INCSOLE | COM | 2.75M | SH | $187.91M 25.02% | 2.75M | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 1.44M | SH | $107.90M 14.36% | 1.44M | 0.00 | 0.00 |
KEROS THERAPEUTICS INCSOLE | COM | 1.44M | SH | $95.06M 12.65% | 1.44M | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 1.48M | SH | $80.78M 10.75% | 1.48M | 0.00 | 0.00 |
ALPINE IMMUNE SCIENCES INCSOLE | COM | 1.98M | SH | $78.57M 10.46% | 1.98M | 0.00 | 0.00 |
BEAM THERAPEUTICS INCSOLE | COM | 2.12M | SH | $70.03M 9.32% | 2.12M | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 832.20K | SH | $55.30M 7.36% | 832.20K | 0.00 | 0.00 |
XENCOR INCSOLE | COM | 1.11M | SH | $24.56M 3.27% | 1.11M | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 473.20K | SH | $17.95M 2.39% | 473.20K | 0.00 | 0.00 |
ELEVATION ONCOLOGY INCSOLE | COM | 2.33M | SH | $11.97M 1.59% | 2.33M | 0.00 | 0.00 |
TOURMALINE BIO INCSOLE | COM | 465K | SH | $10.65M 1.42% | 465K | 0.00 | 0.00 |
MERCK & CO INCSOLE | COM | 79.60K | SH | $10.50M 1.40% | 79.60K | 0.00 | 0.00 |